These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31406252)

  • 21. Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis.
    Zhao J; Zou H; Han C; Ma J; Zhao J; Tang J
    Cell Cycle; 2018; 17(24):2731-2744. PubMed ID: 30521417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1.
    Wu D; Zhang J; Lu Y; Bo S; Li L; Wang L; Zhang Q; Mao J
    Cancer Gene Ther; 2019 Mar; 26(3-4):74-82. PubMed ID: 30032164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a/BRD4 axis.
    Fu B; Liu W; Zhu C; Li P; Wang L; Pan L; Li K; Cai P; Meng M; Wang Y; Zhang A; Tang W; An M
    Int J Biol Sci; 2021; 17(12):3104-3117. PubMed ID: 34421353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
    Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
    Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells.
    Fang Y; Shen H; Cao Y; Li H; Qin R; Chen Q; Long L; Zhu XL; Xie CJ; Xu WL
    Braz J Med Biol Res; 2014 Jan; 47(1):60-9. PubMed ID: 24519092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.
    Gao M; Miao L; Liu M; Li C; Yu C; Yan H; Yin Y; Wang Y; Qi X; Ren J
    Oncotarget; 2016 Sep; 7(37):59714-59726. PubMed ID: 27487127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis.
    Li W; Yang X; Shi C; Zhou Z
    Cell Transplant; 2020; 29():963689720960174. PubMed ID: 32951449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening circular RNA related to chemotherapeutic resistance in breast cancer.
    Gao D; Zhang X; Liu B; Meng D; Fang K; Guo Z; Li L
    Epigenomics; 2017 Sep; 9(9):1175-1188. PubMed ID: 28803498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
    Zhang L; Sun D; Zhang J; Tian Y
    Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
    Wang F; Wang X; Li J; Lv P; Han M; Li L; Chen Z; Dong L; Wang N; Gu Y
    J Biomed Sci; 2021 Jan; 28(1):4. PubMed ID: 33397365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis.
    Xi L; Liu Q; Zhang W; Luo L; Song J; Liu R; Wei S; Wang Y
    Cancer Cell Int; 2021 Mar; 21(1):153. PubMed ID: 33663510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
    Zeng H; Wang L; Wang J; Chen T; Li H; Zhang K; Chen J; Zhen S; Tuluhong D; Li J; Wang S
    Arch Biochem Biophys; 2018 Aug; 651():52-60. PubMed ID: 29802821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircDDX17 acts as a competing endogenous RNA for miR-605 in breast cancer progression.
    Peng HH; Wen YG
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6794-6801. PubMed ID: 32633371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
    Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
    Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.
    Liang G; Ling Y; Mehrpour M; Saw PE; Liu Z; Tan W; Tian Z; Zhong W; Lin W; Luo Q; Lin Q; Li Q; Zhou Y; Hamai A; Codogno P; Li J; Song E; Gong C
    Mol Cancer; 2020 Mar; 19(1):65. PubMed ID: 32213200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.
    Sang Y; Chen B; Song X; Li Y; Liang Y; Han D; Zhang N; Zhang H; Liu Y; Chen T; Li C; Wang L; Zhao W; Yang Q
    Mol Ther; 2019 Sep; 27(9):1638-1652. PubMed ID: 31153828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.